Therapeutic options of endometrial hyperplasia management. Current recommendations and prospective directions of treatment
Endometrial hyperplasia (EH) is a pathological condition characterized by proliferation of the endometrial glands with an increase in the glands/stroma ratio compared to normal proliferative endometrium. EH is a precursor to the development of one of the most common gynecological malignancies – endo...
Main Authors: | T.F. Tatarchuk, T.I. Kvasha, N.F. Zakharenko, N.V. Kosei, V.S. Solskyy, I.V. Shmulian |
---|---|
Format: | Article |
Language: | English |
Published: |
Publishing House TRILIST
2021-09-01
|
Series: | Репродуктивная эндокринология |
Subjects: | |
Online Access: | http://reproduct-endo.com/article/view/243088 |
Similar Items
-
Endometrial hyperplasia and progesterone resistance: a complex relationship
by: Mekan R. Orazov, et al.
Published: (2023-03-01) -
Progestin Resistance and Corresponding Management of Abnormal Endometrial Hyperplasia and Endometrial Carcinoma
by: Mu Lv, et al.
Published: (2022-12-01) -
Influence of obesity on the development of endometrial hyperplasia in women of all ages
by: О. О. Єфіменко, et al.
Published: (2018-10-01) -
Aromatase inhibitor “letrozole” versus progestin “norethisterone” in women with simple endometrial hyperplasia without atypia: A prospective cohort trial
by: M. El-shamy, et al.
Published: (2012-06-01) -
Diagnostic accuracy of hysteroscopic scoring system in predicting endometrial malignancy and atypical endometrial hyperplasia
by: Bhukya Harika, et al.
Published: (2021-01-01)